A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond best to chemotherapy.
Neurons mature and acquire their firing properties with the help of Rbfox genes, a family of genes linked to autism and other neurodevelopmental disorders.
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
Using electron microscopy, CUIMC biologists have captured the first detailed images of a calcium membrane pore in action, revealing a potential target for treating cancer.
At TED 2017, CUMC radiation scientist David Brenner discussed his work using physics to create a new, potentially life-saving weapon against drug-resistant microbes.